AccessPak for HIV PEP Expanded with Kaletra and Ocrelizumab Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Ocrelizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: ocrelizumab
Brand name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Ocrevus
- AccessPak for HIV PEP Expanded with Kaletra-Octagam
- AccessPak for HIV PEP Expanded with Kaletra-Octagam Gammagard S/D
- AccessPak for HIV PEP Expanded with Kaletra-Octocaine
- AccessPak for HIV PEP Expanded with Kaletra-Octocaine 100
- AccessPak for HIV PEP Expanded with Kaletra-OctreoScan
- Ocrelizumab Intravenous-AccessPak for HIV PEP Expanded with Viracept
- Ocrelizumab Intravenous-Accolate
- Ocrelizumab Intravenous-Accretropin
- Ocrelizumab Intravenous-Accucaine
- Ocrelizumab Intravenous-AccuHist Drops
- Ocrelizumab Intravenous-AccuHist PDX Drops